Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
Pharma
ASCO: Novartis details Kisqali's adjuvant breast cancer win
Adding Kisqali to endocrine therapy after surgery reduced the risk of invasive tumor recurrence or death by 25% in certain early-stage breast cancers.
Angus Liu
Jun 2, 2023 8:00am
ASCO: Merck, Novartis to face moment of truth in early cancers
May 25, 2023 3:23pm
Lilly touts how Verzenio helps cancer patients make memories
May 23, 2023 7:50am
'Eligibility challenges' derail GSK's Zejula breast cancer trial
Apr 26, 2023 1:57pm
Roche's new pharma chief talks Tecentriq in early cancers
Apr 26, 2023 9:17am
Novartis' Kisqali, Pluvicto top list of investor concerns
Apr 25, 2023 11:22am
